Acupressure in Rheumatoid Arthritis

Recruiting in Palo Alto (17 mi)

Overseen by Anne Murphy, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Michigan

No Placebo Group

Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial aims to see if acupressure, a method of applying pressure to specific body points, is practical and comfortable for people with rheumatoid arthritis, a painful joint condition.

Research Team

Anne Murphy, MD

Principal Investigator

University of Michigan

Eligibility Criteria

Inclusion Criteria

You are taking the medication called Leflunomide (brand name Arava).

Adalimumab (Humira)

Patient is being treated for Rheumatoid Arthritis (RA) at a Rheumatology Clinic at the University of Michigan or another by rheumatologist and reports being prescribed at least one of the following medications:

Exclusion Criteria

Thrombocytopenia (low platelet count)

Expecting to receive surgery within the next year for their RA

Pregnancy or breast feeding, or anticipate pregnancy in next year

Treatment Details

Interventions

• Acupressure (Behavioural Intervention)

Participant Groups

Group I: Acupressure Experimental Treatment 1 Intervention

The self-acupressure intervention will be delivered using the modified MeTime Acupressure mobile application (App) in addition to in-person or virtual instruction via study staff.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

University of Michigan Ann Arbor, MI

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials

1891

Patients Recruited

6,458,000+